chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A report has been received from a consumer via Health Authority (VAERS), concerning a 5 year old female patient. The patient's medical history included infected insect bite and ear infection. The patient's concurrent disease included congested. On 28-Oct-2009, the patient was receiving FLUMIST (intranasal) for H1N1. Seasonal FLUMIST was given on 23-Sep-2009. Extreme itching and sensitivity in toes spreading to feet, legs and hands developed over several days. She was seen in emergency room on 11-Nov-2009, referred to neurologist, told Guillain-Barre. She treated with TEGRETOL, MOTRIN. She presented with complaints of bilateral foot, toe and hand pain. Later she presented with paresthesias, toes and fingers ache at tips and constipation. Mild Guillain-Barre syndrome was a consideration, dysesthesias consistent with a peripheral neuropathy. Action taken of FLUMIST was unknown. At the time of reporting, the event of Guillain-Barre syndrome was ongoing. According to the company physician the event of Guillain-Barre syndrome was upgraded to serious with the serious criteria of important medical event. Laboratory values were available.
hot cold sweat; hot cold sweat; colds; losing voice; throat is sore; This is a spontaneous report from a Pfizer sponsored program, received from a contactable consumer. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration from an unspecified date to an unspecified date at SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  On unspecified date, the patient experienced colds that results to hot cold sweat and losing voice as her throat is sore. She was due for the second dose on 25Feb2021. The consumer was asking if she could get the second dose of the vaccine on 25Feb2021. She has a terrible cold and is not still over yet. She wanted to get the 2nd dose until she feels better. Outcome of colds was not recovered.  Outcome of hot cold sweat, losing voice, throat is sore was unknown.  Information on the Lot/batch number has been requested.
Patient reported heat going from where I got the shot up into my head. Sensation resolved promptly. No swelling at the site, not discoloration. patient did not experience SOB. He reported feeling fine and wanted to leave. No other reaction noted, no delayed reaction noted. No intervention required. Flushing.
Patient reported she did not feel "herself". She felt like she was someone else. She felt hopeless, depressed and had no motivation for 3-4 weeks. She was startled easily and had nightmares. She missed 3 days of work.
Day 1: Fever, chills, sweating, incontinence, diarrhea, vomiting, extremely cold hands and feet, swollen left arm with large red raised area 6" x 8". Continued through day 3.  Day 3: cold sores, bleeding gums and mouth sores,. Week 2: itchy rash on lower left arm,
This case was reported by a consumer via sales rep and described the occurrence of injection site pain in a 69-year-old male patient who received SHINGRIX (batch number 5CYXDMC P1C ?, GSK note the reported batch number did not match with any GSK lot number expiry date unknown,) for prophylaxis.  In March 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were provided as follows: The patient experienced injection site pain. This case linked with US2019GSK052547, reported by same reporter for the same patient.
Patient received 200 mcg of vaccine instead of 100 mcg Patient was notified and advised to contact our office with ant adverse reactions
began running fever soon p/vax; became anorexic on 18MAY94; dysphagia began 19MAY in PM along w/some raspy, breathing; fever cont & pt began exp wheezing & extreme difficulty breathing; pt examed & found constricted airway, throat red;
Had syncopal episode and lost control of bladder approx 5 minutes after vaccines were administered.  Pt was lowered to the ground.  Lay on the ground for a few minutes.  Nurse reoriented pt and brought to exam room.   Lay in quiet exam room and drank juice until pt was feeling better.  Nurse and Doctor both checked on patient multiple times and pt and mother left office approx 15 minutes after syncopal episode.
mom reports pt recvd vax 9JUN92 pt arm became very swollen & hard & uncomfortable; also temp to about 102 for about 6 days; mom called MD 4th or 5th day; ice to site & cont APAP;
Patient with history of diabetes type II and prostate cancer. He was brought to the ED by EMS on 12/23/22 for evaluation after having multiple falls over the past week. On the date of evaluation, he had two falls. Patient denied any chest pain or shortness of breath. A COVID PCR test performed in the ED on 12/23/22 resulted positive. Patient was admitted 12/23/22 - 12/27/22. Of note, he was found to have an elevated troponin concerning for NSTEMI vs demand ischemia. Discharge diagnoses include NSTEMI vs demand ischemia in setting of COVID-19 and COVID-19 infection, among other diagnoses.
24 hours after vaccine: hand, feet, and back pain. chills. lasted 24 hours 24 hours after vaccine: chest pain, chills, cold sweats lasted 48 hours
Large red Swollen area Upper Left arm, hot to the touch and itchy. Also had pain running down the arm all the way to the wrist. Other symptoms include headache and chills, rapid heartbeat at times. Felt like I had a really bad hangover with fever and chills
PATIENT HAD A LITTLE TINGLING/ITCHINESS JUST AFTER INJECTION BUT RESOLVED BEFORE LEAVING.  A SMALL BRUISE/SPOT AT SITE OF INJECTION WAS PRESENT JUST AFTER INJECTION.  APPROXIMATELY 1 WEEK AFTER INJECTION A SILVER DOLLAR SIZED RED AREA APPEARED THAT WAS PAINFUL, WARM TO THE TOUCH, AND SWOLLEN.  THIS RESOLVED AFTER APPROXIMATELY 3 DAYS.  THE AREA REMAINED RED AT THE TIME THE REACTION WAS REPORTED (2 WEEKS AFTER INJECTION).  PATIENT TOOK BENADRYL BY MOUTH AND USED CORTISONE CREAM TO HELP WITH SWELLING AND ITCHING.
No adverse event reported. I, LPN was given several vaccines by another LPN to give to said patient. Upon charting said vaccines, after they were given, I realized patient had been previously given the same injections the month before. Upon further investigation I found where patient had titer performed for MMR; 9 days prior to first injection and was reactive.
Per nurse at Dr.'s office, and encounter notes form hospital:  the patient experienced severe pain in left deltoid 2 hours after administration of Shingrix on 9/10/19,  which revealed calcium pyrophosphate crystals on aspiration on 9/13/19
Missed the second dose; A spontaneous report was received from a consumer concerning for himself, a 70-year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced event missed the second dose/product dose omission issue,  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 31Jan2021, prior to the onset of the event the patient received first of two planned doses of mRNA-1273 (lot/batch: 030L20A or 630L20A) via unknown route on Left Arm for prophylaxis of COVID-19 infection.  On 28Feb2021, patient missed the second dose because his appointment was cancelled. He was now just getting back from out of town and wants to schedule his second dose.  Action taken with mRNA-1273 in response to the event was Unknown.   The outcome of event Missed the second dose was recovered on 28Feb2021, at the time of this report.
The event began with me feeling extremely cold and unable to warm up.  It later progressed to needle like sensations where ever touched.  I do not remember the next week.  Per my husband I had a sustained temp of 102 and was difficult to keep hydrated.  My O2 sats remained stable.  The following week I became unable to drink anything thicker than water.  This has improved but continues to this day.  My husband is a physician.
Unable to void evening rec'd sec vaccine Narrative: Pt. is an elderly gentleman who has recently had both COVID-19 vaccines, (Pfizer) on 3/23/2021. The next day he started vomiting, had urinary retention, muscle aches and body aches. He was seen in the ED, unsure why he had urinary retention, but the other sx were though to be an adverse rxn to the vaccine. Pt was discharged home with foley catheter in place. 3 days after the vaccine, pt. woke up with a rash on the back of his right leg. It is painful at times, manly when pt. tried washing it. It does not seem to bother patient when he is sitting. Daughter states it is red, raw , and almost like a blister, but flat to the skin No fever, pt. did vomit prior to ED visit on 3/24/2021.
patient had vasovagal reaction, blood pressure dropped 2-3 minutes post vaccine.  he was fine with first dose.  he had similar reaction with a meningococcal vaccine when he was 11.
Case number PHEH2014US003129 is an initial spontaneous report from a medical assistant on 11 FEB 2014 with a follow up information received from the medical assistant on 13 FEB 2014. This report refers to a 19-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number A122102) subcutaneously on 20 JAN 2014. It was reported that on the same day her arm became swollen and there was redness on the upper back of the arm. The event outcome, seriousness and causality were not reported. Follow up information received from the medical assistant on 13 FEB 2014. Treating physician details, patient demographics (date of birth, age) and batch number of MENVEO updated.
about 3:30 the next morning i woke up with dry mouth and went to the bath room and tried to drink water and my throat had closed up and i couldn't breathe I was not able to drink water and and kept gasping for air. finally after a few minutes i was able to catch my breath and i started to wheeze and then my chest hurt when i would breath. And then i woke up today and i was fine.
A report has been received from a Health Professional concerning a 7 year old, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. It was reported that the patient was dosed twice with FLUMIST QUADRIVALENT on 27-Oct-2014 and 28-Oct-2014. The outcome of the event of dosed twice with FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Tongue swolle so large he had to be put on a vent for 10 days, passed away after 2 weeks
Mother reported that at 05:30 8/16/2005 her son awoke with "swollen eyes", "chest pain" (lasting 5 minutes), rapid heart rate, "threw-up one time" and fever (T=101.6F).  These symptoms all resolved by MD eval 12:15pm that same day.
8/4/11 Pts father called stating (L) arm from shoulder to elbow was swollen, red, sore, and a little warm to the touch. No medication had been taken. Pt was with mother traveling out of state. Advised to go to ER since they were traveling.
Presents to the ED c/o increased shortness of breath x2 days.  Patient was diagnosed with COVID on January 4, 2022 and was doing well until 2 days ago we started with increased cough and fever. He did receive the COVID vaccine in February of 2021, but did not receive a COVID booster. Tx.  IV steroid, vitamin-C, zinc, 2 L by nasal cannula.
Muscle aches; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a 70-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced muscle pain. On an unknown date, the outcome of the muscle pain was unknown.   It was unknown if the reporter considered the muscle pain to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient received Shingrix and experienced muscle aches and patient want to know could patient take naproxen for these symptoms.
Chest pain & SOB started 8/30/21 upon waking, came to health clinic @ 0930. Sent to facility for blood work, ECG, and imaging prn.
Temperature increased to 102F with in 24 hours after immunizations on 3/6/03. Rash developed mostly on torso on 3/10/03.
When I got my 1st Moderna vaccine, I had no side effects. When I got my 2nd Moderna vaccine, I had mild aches and pains. Now, after my 3rd Moderna vaccine, I have had a fever of 100 degrees Fahrenheit and aches and pains and felt tired. After taking 1000 mg of acetaminophen my fever went down to 98 degrees, but after 6 hours the fever of 100 degrees Fahrenheit came back.
10/30/12 Feet began to be painful then pain moved to knees, arms, and hands with swelling. Pain on walking. Missed some work secondary difficulty walking secondary pain, swelling, weakness. One episode of fainting after using bathroom. She was referred 11/01 by Employee Health to her PCP. She also saw a rheumatologist x 2 and a neurologist numerous times. She was prescribed at least 10 medications including prednisone, PERCOCET and antidepressant for pain. Symptoms resolved in April 2012. Except for slight swelling of hands and some (lt) shoulder pain, weakness.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Nurse) from product quality group. The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Oct2022 at 17:30 as dose 5 (booster), single (Lot number: G22524) at the age of 51 years, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 30Dec2020 as dose 1, single (Lot number: EK5730), on 19Jan2021 as dose 2, single (Lot number: EL3247), on 13Oct2021 as dose 3 (booster), single (Lot number: FF2587) and on 06Jun2022 as dose 4 (booster), single (Lot number: FM7553), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: PCN" (unspecified if ongoing), notes: Known allergies: PCN. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment; Negative, notes: testing negative twice; Negative, notes: testing negative twice; Positive, notes: new positive test. Therapeutic measures were taken as a result of vaccination failure, covid-19. Treatment of COVID-19 with Paxlovid from 21Dec2022 to 26Dec2022.; Sender's Comments: The efficacy of a vaccine varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine product BNT162B2 to the reported events Vaccination failure and COVID-19 cannot be ruled out.
Chills; Hot flashes; Body aches; Slight headache; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162B2 (DOSE 1), for COVID-19 immunization. The following information was reported: CHILLS (non-serious), outcome "unknown", described as "Chills"; HOT FLUSH (non-serious), outcome "unknown", described as "Hot flashes"; PAIN (non-serious), outcome "unknown", described as "Body aches"; HEADACHE (non-serious), outcome "unknown", described as "Slight headache".  Additional Information: Event took place after use of product. Second dose was given at 09:05 AM. At 11:00 PM, there were chills and then hot flashes. Throughout the night body aches and slight headache. On the day after the second dose, the patient had slight headache and chills.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a licensed visiting nurse concerning a 4 year old female with no medical history or allergies who on 13-MAY-2006 was vaccinated SC with the first and only dose ("1 vial" dose) of VARIVAX (Merck) (lot# not reported). On 01-MAY-2009 the patient developed chickenpox. The lesions spread from her face to arm. Subsequently, the patient recovered from chickenpox. No lab diagnostics studies were performed. The patient was seen by the physician. Additional information has been requested.
neuropathy in both feet and calves and in my hands; My neck and upper back have osteoarthritis; extreme inflammation; excruciating pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in 2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset 2021, outcome "not recovered", described as "excruciating pain"; NEUROPATHY PERIPHERAL (medically significant), outcome "unknown", described as "neuropathy in both feet and calves and in my hands"; SPINAL OSTEOARTHRITIS (non-serious), outcome "unknown", described as "My neck and upper back have osteoarthritis"; INFLAMMATION (non-serious), outcome "unknown", described as "extreme inflammation". Our COVID vaccines gave patient neuropathy in both feet and calves and in their hands. Their neck and upper back had osteoarthritis and extreme inflammation which they never had before. A year and 3 months since the vaccines have left them in excruciating pain. Their life as they knew it was destroyed. They were at 3x a week gym before our vaccines and climbed mountains in between. Now they can hardly get to the supermarket. We need to admit and compensate those of them injured by of our vaccine.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
severe muscle pain, leg and neck; This is a spontaneous report from a contactable consumer (patient). A 67-year-old patient of an unspecified gender received the second dose of bnt162b2 (PFIZER/BIOTECH COVID-19 VACCINE), intramuscularly administered in Left upper arm at the age of 67 years old, on 01Mar2021 14:00 (Batch number: BUD 1540, Lot Number: EN6205) at single dose for Covid-19 immunisation. Vaccination Facility Type: Public Health Clinic. Medical history included heart attack from Jun2019, Quadruple bypass, liver failure from Jan2003 and ongoing, liver transplant in Jan2003. Concomitant medication included tacrolimus (PROGRAF) taken for liver transplant from Jan2003 and ongoing. There were no other vaccines with 4 weeks prior vaccination. The patient previously received the first dose of bnt162b2 (Batch number: BUD 1005, Lot number: EL9269) on 08Feb2021, 9:00 AM intramuscularly on Left upper arm at single dose for covid-19 immunisation. The patient experienced severe muscle pain leg and neck 10-12 days after the 2nd dose. The patient performed multiple tests from 2000 to 2003, with result: Liver failure, on transplant list for 2 years; Cardiogram on 23Jun2019 with result: blocked arteries, comments: Quadruple bypass. No treatment was received, the event didn't require the initiation of new medication /other treatment / procedure. The outcome of the event was unknown. Seriousness Criteria was Not serious.  No follow-up attempts are needed. No further information is expected.
On Tuesday I had a sore throat, headache, feverish, I used my home home COVID-19 test but it came back negative. The next day I felt worse so I retested and this time it came back positive. A friend who is a nurse advised that I call my Primary Care Physician and request the PAXLOVID. My wife called the on call line and they prescribed the medication and I started taking it that evening. Within two days I started feeling better, I do have a bit of a lingering cough but otherwise I feel much better.
Information has been received from a 63 year old female consumer with penicillin allergy who reported that she received a single dose of ZOSTAVAX (Oka/Merck) in April 2008. Concomitant therapy included NEXIUM. The patient recently went on a trip and started experiencing an itchy patch on her upper back. The patch was on her left side, and a week later she had another itchy patch on her lower back. She went to the hospital for check up and the Physician's Assistant there stated that if it was painful he would have said it was shingles. The patches were extremely itchy and hot but not painful at all. The patches started spreading and were mostly confined to her left side. The patches were around her ankles and knees, buttocks and back. There was patch on her right side on her collar bone. The areas were itchy and developed round, red welts that were different sizes and hard to touch. The welts seem to only come out at night. She came back from the trip about a week ago and went to see her physician and a dermatologist. The patient also mentioned that 12 years ago she took prednisone (manufacturer unspecified) and experienced gastroesophageal reflux disease. She was prescribed prednisone for the welts as well as other medication; however the welts were getting worse. Lab diagnostics Studies Performed include a biopsy, the outcomes unknown yet. At the time of reporting the patient was not recovered. No further information is available.
This is a spontaneous report from a contactable consumer reported for oneself. A patient of unspecified age, race/ethnicity and gender received PREVNAR 13, via an unspecified route of administration at single dose on 24Jul2017 for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced got like an itch where they injected me, turned red and kind of a swelling around it on an unspecified date with outcome of unknown.
mom states child very fussy & crying;fever of 101 to 103 day p/vax given;mom states has been giving APAP alternating w/motrin for fever;
Husband drove me this time. Sat there 10 minutes, no problem. Drove 3 miles home. Got out of the car and began feeling dizzy. Sat in lounge chair all day with ice bag over sinus and burning eyes. Was like that for 2 days. 3 days to feel back to myself. More memory loss. Very hard time recalling names or even something just said to me.
Patient is age 12 yrs and weighs 105lbs. .  Patient received adult COVID dose #1 on 11/18/2021.    Patient received Pediatric COVID dose #2 on 12/9/2021.  CDC was called and consulted.  Patient was advised to NOT get any additional doses at this time and patient IS considered fully vaccinated.  This information was related to the parents of the patient on 12/10/2021.
This spontaneous prospective pregnancy report as received from a physician refers to a female patient of an unknown age. The patient's concurrent conditions and medical history were not reported. On 04-NOV-2015, the 9 week pregnant patient was vaccinated with GARDASIL lot # 1010596 and expiry date of 06-APR-2017 inadvertently, when she was indicated to receive a influenza vaccine. The last month period of the patient was approximately 02-SEP-2015 and expected date of delivery was 08-JUN-2016. No adverse effect was reported. Additional information has been requested.